NurExone Biologic(TSE:NRX)
CA$0.47-0.02 (-5.10%)
TSE:NRX
NurExone Biologic financials statements
CA$0.47
At close:-0.02 (-5.10%)
Want to see TSE:NRX full AI Analyst Report?
NurExone Biologic (NRX) Income Statement
13 Followers
NurExone Biologic Income Statement
Last quarter (Q2 2026), NurExone Biologic's total revenue was $0.00. In Q2, NurExone Biologic's net income was $-1.68M. See NurExone Biologic’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 6.32M | $ 5.01M | $ 3.66M | $ 7.62M | $ 1.68M | |
| Depreciation and Amortization | $ 185.00K | $ 85.00K | $ 33.00K | $ 6.00K | $ 0.00 |
| $ -6.17M | $ -4.94M | $ -3.60M | $ -8.13M | $ -1.68M | |
| $ -6.32M | $ -5.01M | $ -3.66M | $ -7.62M | $ -1.68M | |
| $ -61.00K | $ -35.00K | $ 18.00K | $ -550.00K | $ 64.89K | |
| $ -6.38M | $ -5.04M | $ -3.64M | $ -8.17M | $ -1.62M | |
| $ -6.38M | $ -5.04M | $ -3.64M | $ -8.17M | $ -1.62M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.08 | $ -0.08 | $ -0.08 | $ -0.22 | $ -0.99 |
| Diluted EPS | $ -0.08 | $ -0.08 | $ -0.08 | $ -0.22 | $ -0.99 |
| Weighted Average Shares Outstanding | 80.02M | 65.42M | 44.72M | 37.73M | 1.65M |
| Weighted Average Shares Outstanding (Diluted) | 80.02M | 65.42M | 44.72M | 37.73M | 1.65M |
Currency in USD
